Business as usual is not an option for conducting #clinicaltrials in the wake of the #COVID19 pandemic. Customized solutions and #patientcentricity are more optimal approaches in this environment. Jimmy El Hokayem, Ph.D., Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence at Biorasi, shares his insights into #directtopatienttrials
Dermatology Detectives: How the Right Principal Investigator can Increase Patient Trust and Compliance
The success of a clinical trial depends largely on the engagement and experience of the PI. In addition to identifying and recruiting patients, site PIs and their teams conduct study procedures, complete study documentation, and retain patients for outcome assessments.
The success of any clinical trial depends on unbiased data. However, the subjective nature […]
Recognizing early warning signs that your trial is in trouble, and taking quick decisive action, can often get studies back on track. Improving operations can solve most failure risk factors, thus increasing the odds of success.